Stay updated with breaking news from Fierce Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Over the years, melanoma has become a popular testing ground for researchers to explore new immuno-oncology approaches.
Although the overall survival miss won't cost Bavencio its FDA approval, it puts the drug further behind rival PD-1 combos from Merck & Co. and BMS.
While Moderna may have won this battle, the greater COVID vaccine patent war is still ongoing.
(MENAFN - GlobeNewsWire - Nasdaq) The call for submissions is open through June 20NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Questex 's Fierce Pharma today announces the call for submissions for the ... ...
MariTide, formerly AMG 133, is an injectable form of drug targeting two gut hormones — gastric inhibitory polypeptide receptor, or GIP, and glucagon-like peptide 1, or GLP-1.